Joomi Ahn

Dr. Joomi Ahn is Senior Director of Mass Spectrometry at Eli Lilly and Company, where she leads the Mass Spectrometry Analytical Group within Biologics Discovery at the San Diego site. With over 25 years of experience at Lilly, AstraZeneca, and AbbVie, Dr. Ahn has contributed to numerous protein therapeutic pipelines, spanning discovery through early- and late-stage analytical and process development.